These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20079014)

  • 1. [Primary cutaneous anaplastic large cell lymphoma: a clinicopathologic analysis of 8 cases].
    Wang TT; Wang L; Tang ZR; Cheng JR; Li W; Li FY; Wang WY; Li GD
    Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):749-53. PubMed ID: 20079014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Investigation on clinicopathologic features of lymphomatoid papulosis].
    Wang TT; Wang L; Zhang WY; Liao DY; Xu C; Liu WP; Li GD
    Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):668-72. PubMed ID: 20078970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinicopathologic features of 66 cases of anaplastic lymphoma kinase positive and negative systemic anaplastic large cell lymphoma: a comparative study].
    Shi Y; Chen G; Zhou XG; Gong LP; Yu R; Zheng YY; Xie JL; Jin Y
    Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):235-9. PubMed ID: 20654121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cutaneous anaplastic large cell lymphoma: clinicopathologic, immunohistochemical and prognostic study of 44 cases].
    Kong YY; Dai B; Kong JC; Lu HF; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):230-4. PubMed ID: 20654120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary cutaneous CD30-positive anaplastic large cell lymphoma].
    Shi Q; Xu X; Yin H; Zhou X; Zhang T; Sun G; Mikihiro S; Qian B
    Zhonghua Bing Li Xue Za Zhi; 2001 Apr; 30(2):97-100. PubMed ID: 11866962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
    Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
    Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.
    Querfeld C; Khan I; Mahon B; Nelson BP; Rosen ST; Evens AM
    Oncology (Williston Park); 2010 Jun; 24(7):574-87. PubMed ID: 20669794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil/eosinophil-rich type of primary cutaneous anaplastic large cell lymphoma: a clinicopathological, immunophenotypic and molecular study of nine cases.
    Kong YY; Dai B; Kong JC; Lu HF; Shi DR
    Histopathology; 2009 Aug; 55(2):189-96. PubMed ID: 19694826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
    Samols MA; Su A; Ra S; Cappel MA; Louissant A; Knudson RA; Ketterling RP; Said J; Binder S; Harris NL; Feldman AL; Kim J; Kim YH; Gratzinger D
    Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, Histologic, and Molecular Characteristics of Anaplastic Lymphoma Kinase-positive Primary Cutaneous Anaplastic Large Cell Lymphoma.
    Melchers RC; Willemze R; van de Loo M; van Doorn R; Jansen PM; Cleven AHG; Solleveld N; Bekkenk MW; van Kester MS; Diercks GFH; Vermeer MH; Quint KD
    Am J Surg Pathol; 2020 Jun; 44(6):776-781. PubMed ID: 32412717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary cutaneous CD30-positive anaplastic large cell lymphoma analysis.
    Shi Q; Zhou X; Yan X; Xu X; Yin H; Zhong T; Shamoto M; Qian B
    Chin Med J (Engl); 2002 Dec; 115(12):1802-5. PubMed ID: 12622927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sinusoidal CD30-positive large B-cell lymphoma: a morphologic mimic of anaplastic large cell lymphoma.
    Lai R; Medeiros LJ; Dabbagh L; Formenti KS; Coupland RW
    Mod Pathol; 2000 Mar; 13(3):223-8. PubMed ID: 10757332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of expression of 5-hydroxymethylcytosine in CD30-positive cutaneous lymphoproliferative disorders.
    De Souza A; Tinguely M; Pfaltz M; Burghart DR; Kempf W
    J Cutan Pathol; 2014 Dec; 41(12):901-6. PubMed ID: 25353265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyogenic variant of primary cutaneous anaplastic large-cell lymphoma: a lymphoproliferative disorder with a predilection for the immunocompromized and the young.
    Papalas JA; Van Mater D; Wang E
    Am J Dermatopathol; 2010 Dec; 32(8):821-7. PubMed ID: 20881832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of carbohydrate antigens, p80NPM/ALK, cytotoxic cell-associated antigens, and Epstein-Barr virus gene products in anaplastic large cell lymphomas.
    Kasai K; Kon S; Kikuchi K; Sato Y; Kameya T
    Pathol Int; 1998 Mar; 48(3):171-8. PubMed ID: 9589484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes.
    Salhany KE; Macon WR; Choi JK; Elenitsas R; Lessin SR; Felgar RE; Wilson DM; Przybylski GK; Lister J; Wasik MA; Swerdlow SH
    Am J Surg Pathol; 1998 Jul; 22(7):881-93. PubMed ID: 9669350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous CD30-positive anaplastic large cell lymphoma in childhood: report of 4 cases and review of the literature.
    Kumar S; Pittaluga S; Raffeld M; Guerrera M; Seibel NL; Jaffe ES
    Pediatr Dev Pathol; 2005; 8(1):52-60. PubMed ID: 15719203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
    Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
    Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current management of primary cutaneous CD30+ T-cell lymphoproliferative disorders.
    Kadin ME
    Oncology (Williston Park); 2009 Nov; 23(13):1158-64. PubMed ID: 20043465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
    Benner MF; Jansen PM; Meijer CJ; Willemze R
    Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.